EUVIMEDEUVIMED entdecken
Crossref

Correction to “Morpholino Pyrimidine/Pyrimidino‐Oxazines: An Integrated Study as DGAT1 Inhibitors Through QSAR, Molecular Docking, ADMET, and Computational Simulation”

ChemistrySelect · 2026-05 · 11 (19)

DOI: 10.1002/slct.73527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 19.05.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Morpholino Pyrimidine/Pyrimidino‐Oxazines: An Integrated Study as DGAT1 Inhibitors Through QSAR, Molecular Docking, ADMET, and Computational Simulation”. ChemistrySelect, 11(19). https://doi.org/10.1002/slct.73527

Vancouver

Correction to “Morpholino Pyrimidine/Pyrimidino‐Oxazines: An Integrated Study as DGAT1 Inhibitors Through QSAR, Molecular Docking, ADMET, and Computational Simulation”. ChemistrySelect. 2026;11(19). doi:10.1002/slct.73527

BibTeX
@article{euvimed2026,
  title = {Correction to “Morpholino Pyrimidine/Pyrimidino‐Oxazines: An Integrated Study as DGAT1 Inhibitors Through QSAR, Molecular Docking, ADMET, and Computational Simulation”},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {19},
  doi = {10.1002/slct.73527}
}
Kostenlos starten →